Cargando…
Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement
Over the past 13 years, there have been advances in characterizing the patient experience in oncology trials, primarily using patient-reported outcomes (PROs). This review aims to provide details on the PRO measures and analyses used in multiple myeloma (MM) registrational trials. We identified regi...
Autores principales: | Fernandes, Laura L., Zhou, Jiaxi, Kanapuru, Bindu, Horodniceanu, Erica, Gwise, Thomas, Kluetz, Paul G., Bhatnagar, Vishal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408214/ https://www.ncbi.nlm.nih.gov/pubmed/34465728 http://dx.doi.org/10.1038/s41408-021-00543-y |
Ejemplares similares
-
Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
por: Kanapuru, Bindu, et al.
Publicado: (2022) -
Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma
por: Murugappan, Meena N., et al.
Publicado: (2023) -
Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
por: Maignan, Kathleen, et al.
Publicado: (2022) -
Extreme body mass index and survival in newly diagnosed multiple myeloma patients
por: Shah, Urvi A., et al.
Publicado: (2023) -
ASH Highlights and Commentary: Multiple Myeloma
Publicado: (2022)